Nestlé’s Israeli subsidiary Osem Investments has acquired a 51% stake in the country’s largest infant formula producer, Materna Laboratories, from Maabarot Products.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The deal, valued at about NIS252m (US$70.68m), covers Materna’s brand, operations and intellectual property rights.
Maabarot said that the agreement would allow Materna to compete on the global stage.
“As a small company it is impossible to compete internationally but working with a large, well-known and respected corporation like Nestlé opens many doors,” a spokesperson told just-food.
The deal is still subject to antitrust clearance and requires the approval of both companies’ boards.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataNestlé was not available for comment at time of press.
